Many expect GM sales to take a hit from a mishandled recall of small cars, though it’s unclear when and how severe. Any decline would hurt the automaker’s market share and potentially its credit rating.
Guidance 213 is a voluntary plan to phase out some antibiotics on farms. Announced in December, the plan focuses on ridding the food industry from antibiotics used to make animals grow faster and more efficiently than would otherwise be possible.
A Missouri House committee recently endorsed a new law that would put a limit on the awards from medical malpractice suits. The law would cap non-economic awards to a mere $350,000. The cap won’t affect factors like lost income or medical expenses.
Recently, there has been an abnormal rise in calls to US poison control centers regarding electronic cigarettes. The number of calls regarding these devices has increased by a whopping 161%, and local firefighting professionals in the area of Phoenix, Arizona have reported a significant problem with electronic cigarettes starting fires.
A recent investigation conducted by Bloomberg indicates that robotic medical devices have caused serious injury for a large number of patients. In addition to the reported injuries, the survey showed that many robotic surgery injuries often go unreported.
The German pharmaceutical company, Bayer Healthcare, introduced the birth control formulation Yasmin in 2001 and Yaz in 2006. Both preparations were marketed heavily with promises that the drugs were safe and created minimal PMS symptoms of acne and bloating. However, the FDA and other medication regulatory agencies worldwide began receiving reports of serious adverse reactions associated with the medications.
Pradaxa is a blood-thinning medication manufactured by pharmaceutical company Boehlinger Ingleheim for the treatment of a heart condition called atrial fibrillation. The U.S. Food and Drug Administration approved the drug for sale in 2010, but since that time, a number of deaths have been associated with its use. Now, internal documents indicate that the company was aware of a study with negative results that they chose to ignore in order to continue marketing the drug’s advantages.
The National Highway Traffic Safety Administration has insisted on the recall of more than 33,000 safety seats. The car-seats in question go by the name Corrocco or Zeus and are manufactured by Combi USA.